Potential solutions for manufacture of CAR T cells in cancer immunotherapy
Ulrich Blache, Georg Popp, Anna Dünkel, Ulrike Koehl, Stephan Fricke
Abstract
CAR T cell therapy is an effective cancer treatment, but biological and manufacturing hurdles hamper its broad breakthrough. Although the first step towards automated manufacture of CAR cells has been taken, new technologies are needed to enable the treatment of large patient groups.
Topics & Concepts
ImmunotherapyCancer immunotherapyCancer treatmentCancerCancer therapyMedicineInternal medicineCAR-T cell therapy researchNanowire Synthesis and ApplicationsViral Infectious Diseases and Gene Expression in Insects